Skip to content

Visual Quality and Performance of Eyes With Asqelio™ EDoF Toric Lenses

In Situ Analysis of the Optical Quality and Visual Solvency of Eyes Implanted Bilaterally With the Asqelio™ EDoF Toric Extended-focus Intraocular Lens

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06707545
Enrollment
40
Registered
2024-11-27
Start date
2023-01-11
Completion date
2024-05-14
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Presbyopia Correction

Keywords

intraocular lens, extended depth-of-focus, cataract surgery, optical quality

Brief summary

This study evaluates the optical quality and clinical performance of the Asqelio™ EDOF Toric intraocular lens (IOL) in patients undergoing cataract surgery or refractive lensectomy. The Asqelio™ EDOF Toric IOL aims to provide improved vision at various distances and correct astigmatism compared to monofocal IOLs. Postoperative outcomes, including visual clarity, refractive correction, and patient satisfaction, will be assessed three months after surgery.

Detailed description

Cataract surgery is one of the most common procedures worldwide, typically involving the replacement of the cloudy natural lens with an intraocular lens (IOL). Traditional monofocal IOLs correct vision for a single distance but do not address intermediate or near vision, leading to dependence on glasses. The Asqelio™ EDOF Toric IOL is designed to provide extended depth of focus, smoother transitions across distances, and astigmatism correction, potentially enhancing overall visual quality and reducing the need for glasses. This study compares the optical performance and patient outcomes of the Asqelio™ EDOF Toric IOL with those of monofocal IOLs. Key measures include optical quality, visual acuity at multiple distances, refractive correction, and patient-reported satisfaction. Results will be collected during a three-month postoperative follow-up. The findings aim to inform the effectiveness of the Asqelio™ EDOF Toric IOL in improving visual outcomes and quality of life for patients.

Interventions

None listed

Sponsors

AST Products, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 50 years or older who have undergone cataract surgery with phacoemulsification or refractive lensectomy, with bilateral implantation of the Asqelio EDOF toric IOL model ETLIO130C/ETPIO130C with a cylinder value of 0.0 D, or the spherical monofocal J&J TECNIS 1-Piece IOL model ZCB00. * Patients who have signed the informed consent form. * Clear intraocular media, except for the presence of cataracts in both eyes prior to surgery. * Postoperative potential visual acuity of 20/25 or better

Exclusion criteria

* Preoperative corneal astigmatism greater than 1.00D. * Patients who do not provide informed consent. * Patients who do not understand the study procedure. * Previous corneal surgery or trauma. * Irregular cornea (e.g., keratoconus). * Choroidal hemorrhage. * Microphthalmos. * Severe corneal dystrophy. * Uncontrolled or medically controlled glaucoma. * Clinically significant macular changes. * Severe concomitant ocular disease. * Cataract unrelated to aging. * Severe optic nerve atrophy. * Diabetic retinopathy. * Proliferative diabetic retinopathy. * Amblyopia. * Extremely shallow anterior chamber. * Severe chronic uveitis. * Pregnant or breastfeeding. * Rubella. * Mature/dense cataract preventing preoperative fundus examination. * Previous retinal detachment. * Concurrent participation in another drug or clinical device investigation. * Expectation of needing another ocular surgery during the study period

Design outcomes

Primary

MeasureTime frameDescription
Ocular dispersion index (OSI)Three months after intraocular lens implantationOSI value represents the ratio of the amount of light within an annular area of 12 to 20 arc minute and the light corresponding to a circular area of one minute of arc around the central peak. Determined using the OQAS II double pass system
Higher order aberrations Root Mean Square (HORMS)Three months after intraocular lens implantationThe RMS value for higher order aberrations is calculated from the wavefront error map, determined using Hartmann-Shack wavefront aberrometry. Measured in microns
Ocular Spherical AberrationThree months after intraocular lens implantationOcular spherical aberration was determined using Hartmann-Shack wavefront aberrometry. Measured in microns.

Secondary

MeasureTime frameDescription
Monocular visual acuity for distance vision with correction (CDVA)Three months after intraocular lens implantationThe VA with its best correction placed under photopic conditions was determined monocularly at a distance of 4 meters. Measured in LogMAR units
Binocular Contrast sensitivityThree months after intraocular lens implantationDetermined using the best-corrected Pelli-Robson test. Determined in logCS units
Defocus curveThree months after intraocular lens implantationBinocular defocus curve obtained for the EDOF IOL group by varying the vergence of the stimulus from -4.0 D to +2.0 D in steps of 0.5 D with the best correction for distance vision
Monocular visual acuity for distance vision without correction (UDVA)Three months after intraocular lens implantationThe VA without correction under photopic conditions was determined monocularly at a distance of 4 meters. Measured in LogMAR units
Monocular visual acuity for intermediate vision with correction for distance (DCIVA)Three months after intraocular lens implantationThe VA with its best correction placed under photopic conditions was determined monocularly at a distance of 67 centimeters. Measured in LogMAR units
Monocular visual acuity for intermediate vision without correction (UIVA)Three months after intraocular lens implantationThe VA without correction under photopic conditions was determined monocularly at a distance of 67 centimeters. Measured in LogMAR units
Monocular visual acuity for near vision with correction for distance (DCNVA)Three months after intraocular lens implantationThe VA with its best correction placed under photopic conditions was determined monocularly at a distance of 40 centimeters. Measured in LogMAR units
Monocular visual acuity for near vision without correction (UNVA)Three months after intraocular lens implantationThe VA without correction under photopic conditions was determined monocularly at a distance of 40 centimeters. Measured in LogMAR units
Postoperative refractive errorThree months after intraocular lens implantationResidual refractive error. Determined by manifest refraction. Measured in diopters
Monocular Contrast sensitivityThree months after intraocular lens implantationDetermined using the best-corrected Pelli-Robson test. Determined in logCS units
CATQuest 9SFThree months after surgeryPatient-reported outcomes on satisfaction and difficulty performing task after surgery. Obtained for the EDOF IOL group only. Each of the 9 items is scored using the Likert scale, from 1 for no difficulty/very satisfied, to 4 for very great difficulty/very dissatisfied, with higher scores indicating worse visual function.
Visual Symptoms questionnaireThree months after surgeryQuestionnaire exploring the frequency, intensity and bothersome of different visual symptoms. Obtained from the subjects in the EDOF IOL group only.The scoring of these responses ranges from 0 for Never/None to 3 for Very Often/Severe/A lot, with higher scores indicating worse quality of vision

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026